The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGattaca Regulatory News (GATC)

Share Price Information for Gattaca (GATC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 94.00
Bid: 92.00
Ask: 96.00
Change: -2.00 (-2.04%)
Spread: 4.00 (4.348%)
Open: 97.00
High: 96.00
Low: 96.00
Prev. Close: 98.00
GATC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

15 Feb 2024 07:00

RNS Number : 1917D
Gattaca PLC
15 February 2024
 

15 February 2024

 

Gattaca plc

 

("Gattaca" or the "Group")

 

Trading Update

Robust performance in line with market expectations

 

Gattaca plc, the specialist staffing solutions business, today provides the following trading update for the six months ended 31 January 2024 ("H1 24").

 

·

Group Net Fee Income1 ("NFI") expected to be £18.9m (H1 232 £22.5m), a decrease of 16% year-on-year ("YoY")

·

NFI shows anticipated shift towards Contract 76% / Permanent 24% (H1 232: 68% / 32%), reflecting increased focus on contract market and maintaining contractor volumes which ended the period flat with the prior year

·

Permanent NFI down 38% YoY as a result of market weakness, with placements continuing to show weakness since the turn of the year, and the exit of a large permanent Recruitment Process Outsourcing ("RPO") client in prior year as referenced at year end

·

Significant progress in business development, with two large client extensions and two more Managed Service Provider wins

·

Defence continues to be the Group's strongest performing sector with 9% YoY growth excluding the RPO account exit as above

·

Marginal reduction in sales headcount during H1 24 to 312 from 315 at the year-end, focused UK headcount investment in specific sectors showing growth opportunities, these being Energy, Defence and Gattaca Projects

·

The Group expects to report statutory net cash at 31 January 2024 of £22.1m (31 July 2023: net cash of £21.6m)

 

 

Notice of Interim Results

The Group will announce its results for the six months to 31 January 2024 on Tuesday 16 April 2024.

 

 

Matthew Wragg, Chief Executive Officer said:

"Despite the tough market conditions, I am pleased to report the Group is trading in line with current market expectations. I am also pleased to see our strategy to invest in business development is starting to bear fruit, with two large client extensions and two more Managed Service Provider (MSP) wins for the Group in H1 and a growing pipeline. We continue to see high engagement, staff attrition below long-term targets and productivity levels beginning to improve. In H1 we have continued to focus the business more on specific markets and geographies. We have reduced our workforce in North America.

 

However, the economic conditions have led to a challenging market in H1 and we have not been immune to this. Permanant fee income is down 38% due to much lower than anticipated volumes at the back end of 2023 and compounded by reduced NFI from the exiting of a major programme last year. We anticipate that Permanant fees will pick up gradually as we go through 2024. Contract income has remained stable, and we are starting to see growth from our investment and focus into this area.

 

Recognising that trading conditions are expected to remain challenging, we plan to keep tight control on operating costs including headcount during H2, whilst we are mindful to ensure we are well placed to build market share in our chosen sectors as the economy recovers.

 

I would like to add my personal thanks to everyone in and from the business, our special community, customers and partners for their support in what has been an extremely tough week for the Group following the sudden passing of our very good friend and Chief Sales Officer Grahame Carter. The way everyone has united is testament to the strength we have as a team. Our love and condolences go to his family, friends and everyone who had the pleasure to know him."

 

 

1. NFI is calculated as revenue less contractor payroll costs

2. H1 23 results have been restated for the correction of a FY22 revenue cut-off error, and the FY23 reassessment of the Group's accounting policy over how accrued revenue and accrued cost balances have been calculated at the period end. The aggregated impact of these items on H1 23 reported NFI is £0.2m reduction. Further details on this error and policy change were provided in the Group's FY23 Annual Report & Accounts.

 

 

 

For further information please contact:

 

Gattaca plc

+44 (0) 1489 898989

Matthew Wragg, Chief Executive Officer 

Oliver Whittaker, Chief Financial Officer

Liberum Capital Limited (Nomad and Broker)

+44 (0) 20 3100 2000

Lauren Kettle

Richard Lindley

IFC Advisory (Financial PR and IR)

+44 (0) 203 934 6630

Tim Metcalfe

Graham Herring

Florence Chandler

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBIGDDUXBDGSS
Date   Source Headline
3rd May 20237:00 amRNSTransaction in Own Shares
2nd May 20237:00 amRNSTransaction in Own Shares
26th Apr 20237:00 amRNSTransaction in Own Shares
25th Apr 20237:00 amRNSTransaction in Own Shares
24th Apr 20237:00 amRNSTransaction in Own Shares
21st Apr 20237:00 amRNSTransaction in Own Shares
20th Apr 20237:00 amRNSTransaction in Own Shares
19th Apr 20237:00 amRNSTransaction in Own Shares
17th Apr 20237:00 amRNSTransaction in Own Shares
14th Apr 20237:00 amRNSTransaction in Own Shares
3rd Apr 20237:01 amRNSBlock Listing Six Monthly Return
3rd Apr 20237:00 amRNSLaunch of Share Buy-back
30th Mar 20237:00 amRNSInterim results
15th Feb 20234:40 pmRNSSecond Price Monitoring Extn
15th Feb 20234:35 pmRNSPrice Monitoring Extension
15th Feb 20237:00 amRNSTrading Statement
10th Feb 20239:05 amRNSSecond Price Monitoring Extn
10th Feb 20239:00 amRNSPrice Monitoring Extension
14th Dec 20223:02 pmRNSIssue of Ordinary Shares & Total Voting Rights
6th Dec 20221:55 pmRNSDirector/PDMR Shareholding
6th Dec 202212:55 pmRNSResult of AGM
3rd Nov 20227:00 amRNSPreliminary Results for the year ended 31 July 22
3rd Oct 202211:03 amRNSBlock Listing Six Monthly Return
29th Sep 20224:54 pmRNSEBT Share Purchase Programme
17th Aug 20227:00 amRNSTrading Update
8th Jul 202211:05 amRNSSecond Price Monitoring Extn
8th Jul 202211:00 amRNSPrice Monitoring Extension
8th Jul 20229:06 amRNSSecond Price Monitoring Extn
8th Jul 20229:00 amRNSPrice Monitoring Extension
6th May 202211:55 amRNSDirector/PDMR Shareholding
4th Apr 20224:20 pmRNSConfirmation of Director Appointment
1st Apr 20229:35 amRNSBlock listing six monthly return
31st Mar 20227:00 amRNSInterim Results
15th Mar 20227:00 amRNSBoard Succession
18th Jan 20229:05 amRNSSecond Price Monitoring Extn
18th Jan 20229:00 amRNSPrice Monitoring Extension
18th Jan 20227:00 amRNSTrading Update
16th Dec 20211:40 pmRNSDirector/PDMR Shareholding
8th Dec 20214:14 pmRNSResult of AGM
8th Dec 20214:10 pmRNSDirectorate Change
2nd Dec 202111:06 amRNSSecond Price Monitoring Extn
2nd Dec 202111:00 amRNSPrice Monitoring Extension
4th Nov 20219:05 amRNSSecond Price Monitoring Extn
4th Nov 20219:00 amRNSPrice Monitoring Extension
4th Nov 20217:00 amRNSPreliminary Results for the year ended 31 July 21
1st Oct 20219:09 amRNSBlock Listing Six Monthly Return
20th Sep 202111:00 amRNSPrice Monitoring Extension
17th Aug 20217:00 amRNSTrading Update
13th Jul 202110:50 amRNSDirector/PDMR Shareholding
17th Jun 202112:01 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.